Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206


Temporal relationship between 18F-sodium fluoride uptake in the abdominal aorta and evolution of CT-verified vascular calcification.

Nakahara T, Narula J, Fox JJ, Jinzaki M, Strauss HW.

J Nucl Cardiol. 2019 Nov 18. doi: 10.1007/s12350-019-01934-2. [Epub ahead of print]


Mass cytometry reveals species-specific differences and a new level of complexity for immune cells in the prostate.

Fox JJ, Navarro HI, Hashimoto T, Garcia AJ, Goldstein AS.

Am J Clin Exp Urol. 2019 Aug 15;7(4):281-296. eCollection 2019.


Expansion of Luminal Progenitor Cells in the Aging Mouse and Human Prostate.

Crowell PD, Fox JJ, Hashimoto T, Diaz JA, Navarro HI, Henry GH, Feldmar BA, Lowe MG, Garcia AJ, Wu YE, Sajed DP, Strand DW, Goldstein AS.

Cell Rep. 2019 Aug 6;28(6):1499-1510.e6. doi: 10.1016/j.celrep.2019.07.007.


Pharmacokinetics and Biodistribution of a [89Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients.

O'Donoghue JA, Danila DC, Pandit-Taskar N, Beylergil V, Cheal SM, Fleming SE, Fox JJ, Ruan S, Zanzonico PB, Ragupathi G, Lyashchenko SK, Williams SP, Scher HI, Fine BM, Humm JL, Larson SM, Morris MJ, Carrasquillo JA.

Mol Pharm. 2019 Jul 1;16(7):3083-3090. doi: 10.1021/acs.molpharmaceut.9b00326. Epub 2019 May 31.


Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using 89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody.

Carrasquillo JA, Fine BM, Pandit-Taskar N, Larson SM, Fleming SE, Fox JJ, Cheal SM, O'Donoghue JA, Ruan S, Ragupathi G, Lyashchenko SK, Humm JL, Scher HI, Gönen M, Williams SP, Danila DC, Morris MJ.

J Nucl Med. 2019 Nov;60(11):1517-1523. doi: 10.2967/jnumed.118.222844. Epub 2019 May 3.


Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials.

Mota JM, Armstrong AJ, Larson SM, Fox JJ, Morris MJ.

Prostate Cancer Prostatic Dis. 2019 Dec;22(4):522-530. doi: 10.1038/s41391-019-0151-4. Epub 2019 Apr 29. Review.


Structural Design for Stretchable Microstrip Antennas.

Zhu J, Fox JJ, Yi N, Cheng H.

ACS Appl Mater Interfaces. 2019 Mar 6;11(9):8867-8877. doi: 10.1021/acsami.8b22021. Epub 2019 Feb 25.


Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.

Fox JJ, Gavane SC, Blanc-Autran E, Nehmeh S, Gönen M, Beattie B, Vargas HA, Schöder H, Humm JL, Fine SW, Lewis JS, Solomon SB, Osborne JR, Veach D, Sawyers CL, Weber WA, Scher HI, Morris MJ, Larson SM.

JAMA Oncol. 2018 Feb 1;4(2):217-224. doi: 10.1001/jamaoncol.2017.3588.


Successful Minimally Invasive Mitral Valve Replacement Using Normothermic Fibrillatory Arrest in a Patient With Cold Urticaria.

Nelson JA, Maltais S, Fox JJ, Hagan JB, Rossow KL, Mauermann WJ.

J Cardiothorac Vasc Anesth. 2018 Apr;32(2):935-937. doi: 10.1053/j.jvca.2017.05.001. Epub 2017 May 3. No abstract available.


The Precision of Hepatic Arterial Infusion Scintigraphy as a Quantitative Biomarker of Tumor Microvasculature.

Dunphy M, Pandit-Taskar N, Fox JJ, Kemeny N.

AJR Am J Roentgenol. 2017 Jul;209(1):182-186. doi: 10.2214/AJR.16.17560. Epub 2017 May 24.


Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis Imaging.

Pandit-Taskar N, Veach DR, Fox JJ, Scher HI, Morris MJ, Larson SM.

J Nucl Med. 2016 Oct;57(Suppl 3):73S-78S.



Vargas HA, Wassberg C, Fox JJ, Wibmer A, Goldman DA, Kuk D, Gonen M, Larson SM, Morris MJ, Scher HI, Hricak H.

Radiology. 2015 Feb;274(2):625. No abstract available.


Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomography.

Casey DL, Wexler LH, Fox JJ, Dharmarajan KV, Schoder H, Price AN, Wolden SL.

Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1136-42. doi: 10.1016/j.ijrobp.2014.08.005.


Noncontrast perfusion single-photon emission CT/CT scanning: a new test for the expedited, high-accuracy diagnosis of acute pulmonary embolism.

Lu Y, Lorenzoni A, Fox JJ, Rademaker J, Vander Els N, Grewal RK, Strauss HW, Schöder H.

Chest. 2014 May;145(5):1079-1088. doi: 10.1378/chest.13-2090.


Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival.

Vargas HA, Wassberg C, Fox JJ, Wibmer A, Goldman DA, Kuk D, Gonen M, Larson SM, Morris MJ, Scher HI, Hricak H.

Radiology. 2014 Apr;271(1):220-9. doi: 10.1148/radiol.13130625. Epub 2013 Nov 18.


Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer.

Rathkopf DE, Morris MJ, Fox JJ, Danila DC, Slovin SF, Hager JH, Rix PJ, Chow Maneval E, Chen I, Gönen M, Fleisher M, Larson SM, Sawyers CL, Scher HI.

J Clin Oncol. 2013 Oct 1;31(28):3525-30. doi: 10.1200/JCO.2013.50.1684. Epub 2013 Sep 3.


Pancreatic involvement in neuroblastoma with radiologic-pathologic correlation: a single-institution experience.

Rosenbaum DG, Abramson SJ, DeLappe E, Teruya-Feldstein J, La Quaglia MP, Fox JJ, Price AP.

AJR Am J Roentgenol. 2013 Jul;201(1):W141-6. doi: 10.2214/AJR.12.9618.


Successful management of gastric perforation in stage IV diffuse large B-cell lymphoma with chemoradiation therapy, percutaneous endoscopy gastrostomy for gastric drainage, and percutaneous endoscopy jejunostomy for nutrition.

Khadraoui H, Feigin KN, Fox JJ, Ong L, Shike M, Yahalom J, Noy A.

Clin Lymphoma Myeloma Leuk. 2013 Jun;13(3):327-30. doi: 10.1016/j.clml.2012.11.005. Epub 2012 Dec 23. No abstract available.


Molecular imaging of prostate cancer.

Fox JJ, Schöder H, Larson SM.

Curr Opin Urol. 2012 Jul;22(4):320-7. doi: 10.1097/MOU.0b013e32835483d5. Review.


Positron emission tomography (PET) evaluation after initial chemotherapy and radiation therapy predicts local control in rhabdomyosarcoma.

Dharmarajan KV, Wexler LH, Gavane S, Fox JJ, Schoder H, Tom AK, Price AN, Meyers PA, Wolden SL.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):996-1002. doi: 10.1016/j.ijrobp.2012.01.077. Epub 2012 May 5.


A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.

Ulmert D, Kaboteh R, Fox JJ, Savage C, Evans MJ, Lilja H, Abrahamsson PA, Björk T, Gerdtsson A, Bjartell A, Gjertsson P, Höglund P, Lomsky M, Ohlsson M, Richter J, Sadik M, Morris MJ, Scher HI, Sjöstrand K, Yu A, Suurküla M, Edenbrandt L, Larson SM.

Eur Urol. 2012 Jul;62(1):78-84. doi: 10.1016/j.eururo.2012.01.037. Epub 2012 Jan 27.


Bone scan index: a quantitative treatment response biomarker for castration-resistant metastatic prostate cancer.

Dennis ER, Jia X, Mezheritskiy IS, Stephenson RD, Schoder H, Fox JJ, Heller G, Scher HI, Larson SM, Morris MJ.

J Clin Oncol. 2012 Feb 10;30(5):519-24. doi: 10.1200/JCO.2011.36.5791. Epub 2012 Jan 9.


Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CT.

Fox JJ, Autran-Blanc E, Morris MJ, Gavane S, Nehmeh S, Van Nuffel A, Gönen M, Schöder H, Humm JL, Scher HI, Larson SM.

J Nucl Med. 2011 Nov;52(11):1727-32. doi: 10.2967/jnumed.111.089326. Epub 2011 Oct 7.


Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen.

Banerjee SR, Pullambhatla M, Byun Y, Nimmagadda S, Foss CA, Green G, Fox JJ, Lupold SE, Mease RC, Pomper MG.

Angew Chem Int Ed Engl. 2011 Sep 19;50(39):9167-70. doi: 10.1002/anie.201102872. Epub 2011 Aug 22. No abstract available.


Imaging CXCR4 expression in human cancer xenografts: evaluation of monocyclam 64Cu-AMD3465.

De Silva RA, Peyre K, Pullambhatla M, Fox JJ, Pomper MG, Nimmagadda S.

J Nucl Med. 2011 Jun;52(6):986-93. doi: 10.2967/jnumed.110.085613.


Developing imaging strategies for castration resistant prostate cancer.

Fox JJ, Morris MJ, Larson SM, Schöder H, Scher HI.

Acta Oncol. 2011 Jun;50 Suppl 1:39-48. doi: 10.3109/0284186X.2011.572914.


Mobilizing the fountain of youth within.

Strauss HW, Fox JJ.

J Nucl Cardiol. 2011 May;18(3):396-7. doi: 10.1007/s12350-011-9363-2. No abstract available.


Acute pulmonary embolism detected by perfusion SPECT/CT masquerading as an intermediate probability planar V/Q scan.

Lu Y, Fox JJ.

Clin Nucl Med. 2010 Dec;35(12):941-3. doi: 10.1097/RLU.0b013e3181f9de54. No abstract available.


Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancer.

Meirelles GS, Schöder H, Ravizzini GC, Gönen M, Fox JJ, Humm J, Morris MJ, Scher HI, Larson SM.

Clin Cancer Res. 2010 Dec 15;16(24):6093-9. doi: 10.1158/1078-0432.CCR-10-1357. Epub 2010 Oct 25.


68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer.

Banerjee SR, Pullambhatla M, Byun Y, Nimmagadda S, Green G, Fox JJ, Horti A, Mease RC, Pomper MG.

J Med Chem. 2010 Jul 22;53(14):5333-41. doi: 10.1021/jm100623e.


Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies.

Wang H, Byun Y, Barinka C, Pullambhatla M, Bhang HE, Fox JJ, Lubkowski J, Mease RC, Pomper MG.

Bioorg Med Chem Lett. 2010 Jan 1;20(1):392-7. doi: 10.1016/j.bmcl.2009.10.061. Epub 2009 Oct 24.


Cross-talk between signaling pathways can generate robust oscillations in calcium and cAMP.

Siso-Nadal F, Fox JJ, Laporte SA, Hébert TE, Swain PS.

PLoS One. 2009 Oct 21;4(10):e7189. doi: 10.1371/journal.pone.0007189.


Radiological impact of the use of calcium hydroxylapatite dermal fillers.

Feeney JN, Fox JJ, Akhurst T.

Clin Radiol. 2009 Sep;64(9):897-902. doi: 10.1016/j.crad.2009.05.004. Epub 2009 Jul 5.


Breast carcinoma metastatic to renal oncocytoma detected on F-18-FDG PET/CT.

Fox JJ, Rohan S, Pandit-Taskar N.

Clin Nucl Med. 2009 May;34(5):294-5. doi: 10.1097/RLU.0b013e31819e51ce. No abstract available.


Identification of Ikr kinetics and drug binding in native myocytes.

Zhou Q, Zygmunt AC, Cordeiro JM, Siso-Nadal F, Miller RE, Buzzard GT, Fox JJ.

Ann Biomed Eng. 2009 Jul;37(7):1294-309. doi: 10.1007/s10439-009-9690-5. Epub 2009 Apr 8.


One step closer to imaging vulnerable plaque in the coronary arteries.

Fox JJ, Strauss HW.

J Nucl Med. 2009 Apr;50(4):497-500. doi: 10.2967/jnumed.108.056325. Epub 2009 Mar 16. No abstract available.


Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models.

Pomper MG, Hammond H, Yu X, Ye Z, Foss CA, Lin DD, Fox JJ, Cheng L.

Cell Res. 2009 Mar;19(3):370-9. doi: 10.1038/cr.2008.329.


Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer.

Chen Y, Foss CA, Byun Y, Nimmagadda S, Pullambhatla M, Fox JJ, Castanares M, Lupold SE, Babich JW, Mease RC, Pomper MG.

J Med Chem. 2008 Dec 25;51(24):7933-43. doi: 10.1021/jm801055h.


Boundary-induced reentry in homogeneous excitable tissue.

Siso-Nadal F, Otani NF, Gilmour RF Jr, Fox JJ.

Phys Rev E Stat Nonlin Soft Matter Phys. 2008 Sep;78(3 Pt 1):031925. Epub 2008 Sep 29.


An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer.

Song H, Shahverdi K, Huso DL, Wang Y, Fox JJ, Hobbs RF, Gimi B, Gabrielson KL, Pomper MG, Tsui BM, Bhujwalla Z, Reilly RT, Sgouros G.

Clin Cancer Res. 2008 Oct 1;14(19):6116-24. doi: 10.1158/1078-0432.CCR-07-4672.


Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.

Fu DX, Tanhehco Y, Chen J, Foss CA, Fox JJ, Chong JM, Hobbs RF, Fukayama M, Sgouros G, Kowalski J, Pomper MG, Ambinder RF.

Nat Med. 2008 Oct;14(10):1118-22. doi: 10.1038/nm.1864. Epub 2008 Sep 7.


Dynamic mechanism for initiation of ventricular fibrillation in vivo.

Gelzer AR, Koller ML, Otani NF, Fox JJ, Enyeart MW, Hooker GJ, Riccio ML, Bartoli CR, Gilmour RF Jr.

Circulation. 2008 Sep 9;118(11):1123-9. doi: 10.1161/CIRCULATIONAHA.107.738013. Epub 2008 Aug 25.


Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).

Banerjee SR, Foss CA, Castanares M, Mease RC, Byun Y, Fox JJ, Hilton J, Lupold SE, Kozikowski AP, Pomper MG.

J Med Chem. 2008 Aug 14;51(15):4504-17. doi: 10.1021/jm800111u. Epub 2008 Jul 19.


In vivo PET imaging of cardiac presynaptic sympathoneuronal mechanisms in the rat.

Tipre DN, Fox JJ, Holt DP, Green G, Yu J, Pomper M, Dannals RF, Bengel FM.

J Nucl Med. 2008 Jul;49(7):1189-95. doi: 10.2967/jnumed.107.050252. Epub 2008 Jun 13.


N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer.

Mease RC, Dusich CL, Foss CA, Ravert HT, Dannals RF, Seidel J, Prideaux A, Fox JJ, Sgouros G, Kozikowski AP, Pomper MG.

Clin Cancer Res. 2008 May 15;14(10):3036-43. doi: 10.1158/1078-0432.CCR-07-1517.


Computationally efficient strategy for modeling the effect of ion current modifiers.

Rand DG, Zhou Q, Buzzard GT, Fox JJ.

IEEE Trans Biomed Eng. 2008 Jan;55(1):3-13. doi: 10.1109/TBME.2007.896594.


The plateau outward current in canine ventricle, sensitive to 4-aminopyridine, is a constitutive contributor to ventricular repolarization.

Sridhar A, da Cunha DN, Lacombe VA, Zhou Q, Fox JJ, Hamlin RL, Carnes CA.

Br J Pharmacol. 2007 Nov;152(6):870-9. Epub 2007 Aug 13.


Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer.

Foss CA, Fox JJ, Feldmann G, Maitra A, Iacobuzio-Donohue C, Kern SE, Hruban R, Pomper MG.

Mol Imaging. 2007 Mar-Apr;6(2):131-9.


Virus-associated tumor imaging by induction of viral gene expression.

Fu DX, Tanhehco YC, Chen J, Foss CA, Fox JJ, Lemas V, Chong JM, Ambinder RF, Pomper MG.

Clin Cancer Res. 2007 Mar 1;13(5):1453-8.


Control of electrical alternans in canine cardiac purkinje fibers.

Christini DJ, Riccio ML, Culianu CA, Fox JJ, Karma A, Gilmour RF Jr.

Phys Rev Lett. 2006 Mar 17;96(10):104101. Epub 2006 Mar 17.

Supplemental Content

Support Center